当前位置: 首页 >> 检索结果
4002. Risk Factors for Dysphagia in ICU Patients After Invasive Mechanical Ventilation.
作者: Patrick Zuercher.;Noëlle V Schenk.;Céline Moret.;David Berger.;Roman Abegglen.;Joerg C Schefold.
来源: Chest. 2020年158卷5期1983-1991页
Dysphagia is common and independently predicts death in ICU patients. Risk factors for dysphagia are largely unknown, with sparse data available from mostly small cohorts without systematic dysphagia screening.
4004. Key Highlights From the Canadian Thoracic Society's Position Statement on Optimizing the Management of Sleep Disordered Breathing During the Coronavirus Disease 2019 Pandemic.
作者: Najib T Ayas.;Kristin L Fraser.;Eleni Giannouli.;Patrick J Hanly.;Tetyana Kendzerska.;Sherri Lynne Katz.;Brandy N Lachmann.;Annie Lajoie.;Caroline Minville.;Debra Morrison.;Indra Narang.;Marcus Povitz.;Robert Skomro.;Kathy F Spurr.
来源: Chest. 2020年158卷3期899-900页 4005. Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome.
作者: Romain Barthélémy.;Pierre-Louis Blot.;Ambre Tiepolo.;Arthur Le Gall.;Claire Mayeur.;Samuel Gaugain.;Louis Morisson.;Etienne Gayat.;Alexandre Mebazaa.;Benjamin Glenn Chousterman.
来源: Chest. 2020年158卷5期2003-2006页 4006. Use of Tracheostomy During the COVID-19 Pandemic: American College of Chest Physicians/American Association for Bronchology and Interventional Pulmonology/Association of Interventional Pulmonology Program Directors Expert Panel Report.
作者: Carla R Lamb.;Neeraj R Desai.;Luis Angel.;Udit Chaddha.;Ashutosh Sachdeva.;Sonali Sethi.;Hassan Bencheqroun.;Hiren Mehta.;Jason Akulian.;A Christine Argento.;Javier Diaz-Mendoza.;Ali Musani.;Septimiu Murgu.
来源: Chest. 2020年158卷4期1499-1514页
The role of tracheostomy during the coronavirus disease 2019 (COVID-19) pandemic remains unknown. The goal of this consensus statement is to examine the current evidence for performing tracheostomy in patients with respiratory failure from COVID-19 and offer guidance to physicians on the preparation, timing, and technique while minimizing the risk of infection to health care workers (HCWs).
4008. A 52-Year-Old Man With Cough, Dyspnea, and Diffuse Parenchymal Lung Disease for 5 Years.
A 52-year-old man presented with repeated cough and worsening exertional dyspnea for 5 years. Long-term oral prednisone had been administered with little effect. He denied chest pain, hemoptysis, or nighttime paroxysmal dyspnea. His medical history included chronic hepatitis B, liver cirrhosis, splenomegaly, diabetes insipidus, and hypertension. He denied consuming alcohol or illicit drugs. He was a never smoker. His family history was noncontributory.
4009. A Pregnant Woman Presenting With Progressively Worsening Dyspnea and Pneumothorax.
作者: Arun Agrawal.;Ethan Karle.;Tarang Pankaj Patel.;Grace Wilson.;Hunter Hofmann.;Ramez Sunna.;Armin Krvavac.
来源: Chest. 2020年157卷6期e193-e196页
A 29-year-old Ukrainian woman presented to the obstetric clinic at 28 weeks' gestation with pregnancy complicated by intrauterine growth restriction. She reported progressively worsening dyspnea during her pregnancy and was found to have significant hypoxia with an oxygen saturation of 84% on room air prompting admission for further evaluation. Oxygen saturation improved to 92% on 10 L of supplemental oxygen. On further questioning, she was found to have a history significant for pleurodesis as a treatment for recurrent pneumothoraces and nephrectomy for a benign renal mass several years prior while living in Ukraine.
4010. A 53-Year-Old Woman With Dyspnea, Wheezing, and Irreversible Airway Obstruction.
作者: Elizabeth Belloli.;Kristine Konopka.;Jeffrey Myers.;Robert Hyzy.
来源: Chest. 2020年157卷6期e189-e192页
A previously healthy 53-year-old woman with 4 months of dyspnea and subjective wheezing presented to pulmonary clinic for a second opinion. Her medical history included hypertension, obesity, and OSA. She had been hospitalized 3 months prior at an outside hospital for evaluation of these symptoms. She had never smoked. She was a retired teacher and previously served as a pet nanny to dogs and cats. She denied antecedent respiratory infection or environmental exposure before the onset of her symptoms. Current medications included budesonide-formoterol, tiotropium, loratadine, and montelukast. She did not experience significant change in symptoms with bronchodilators or corticosteroid treatment.
4011. e-Cigarette or Vaping Product Use-Associated Lung Injury: Clinical, Radiologic, and Pathologic Findings of 15 Cases.
作者: Maeve MacMurdo.;Charlie Lin.;Mnahi Bin Saeedan.;Erika E Doxtader.;Sanjay Mukhopadhyay.;Valeria Arrossi.;Jordan Reynolds.;Subha Ghosh.;Humberto Choi.
来源: Chest. 2020年157卷6期e181-e187页
Since mid-2019, > 2,000 cases of e-cigarette or vaping product use-associated lung injury (EVALI) have been reported. Although initial reports suggested that this entity may be a form of inhalation-related lipoid pneumonia, subsequent studies indicate that EVALI represents various patterns of acute lung injury. Cases of EVALI continue to be reported, and public awareness of the epidemic is increasingly high. However, evidence surrounding optimal management of EVALI remains limited. In this case series, we report 15 cases of EVALI across a spectrum of severity, highlighting key radiologic, pathologic, and cytologic findings, and discuss management implications. In line with national findings, most patients with EVALI in the series vaped liquids containing tetrahydrocannabinol. Our imaging and pathologic findings support the notion that EVALI is a form of acute lung injury.
|